• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Synaptic Oligomers and Glial Cells in Alzheimer Disease.

作者信息

Grinberg Lea Tenenholz

机构信息

Department of Neurology, University of California, San Francisco.

Department of Pathology, University of California, San Francisco.

出版信息

JAMA Neurol. 2023 Nov 1;80(11):1136-1137. doi: 10.1001/jamaneurol.2023.3539.

DOI:10.1001/jamaneurol.2023.3539
PMID:37812438
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10903969/
Abstract
摘要

相似文献

1
Synaptic Oligomers and Glial Cells in Alzheimer Disease.阿尔茨海默病中的突触寡聚体与神经胶质细胞
JAMA Neurol. 2023 Nov 1;80(11):1136-1137. doi: 10.1001/jamaneurol.2023.3539.
2
A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo.淀粉样β寡聚体的小鼠模型：其对体内突触改变、异常tau 磷酸化、神经胶质细胞激活和神经元丢失的贡献。
J Neurosci. 2010 Apr 7;30(14):4845-56. doi: 10.1523/JNEUROSCI.5825-09.2010.
3
Tau Oligomer-Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer Disease.阿尔茨海默病中小胶质细胞和星形胶质细胞清除含有 Tau 寡聚物的突触。
JAMA Neurol. 2023 Nov 1;80(11):1209-1221. doi: 10.1001/jamaneurol.2023.3530.
4
The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer's disease.阿尔茨海默病中突触生物标志物与β淀粉样蛋白、tau蛋白、神经胶质细胞激活及神经退行性变的关系。
Transl Neurodegener. 2024 May 28;13(1):27. doi: 10.1186/s40035-024-00420-1.
5
Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins.阿尔茨海默病和淀粉样前体蛋白转基因小鼠中淀粉样-β寡聚体的进行性积累伴随着突触支架蛋白的选择性改变。
FEBS J. 2010 Jul;277(14):3051-67. doi: 10.1111/j.1742-4658.2010.07719.x. Epub 2010 Jun 22.
6
Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.靶向淀粉样β-蛋白1-42寡聚体的阿尔茨海默病治疗方法I：药物候选物可取代与特定神经元受体结合的β-淀粉样蛋白42寡聚体，从而改善认知缺陷。
PLoS One. 2014 Nov 12;9(11):e111898. doi: 10.1371/journal.pone.0111898. eCollection 2014.
7
Aβ oligomers: role at the synapse.淀粉样β寡聚体：在突触中的作用。
Aging (Albany NY). 2019 Feb 8;11(4):1077-1078. doi: 10.18632/aging.101818.
8
Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer's disease.Toll 样受体 4 依赖性神经胶质细胞激活介导β淀粉样寡聚体在阿尔茨海默病急性小鼠模型中引起的记忆形成障碍。
Brain Behav Immun. 2017 Feb;60:188-197. doi: 10.1016/j.bbi.2016.10.012. Epub 2016 Oct 14.
9
Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer's disease neuropathology.认知功能正常的阿尔茨海默病病理患者的突触后不存在淀粉样 β 寡聚体和调节性突触 Zn2+。
Mol Neurodegener. 2012 May 28;7:23. doi: 10.1186/1750-1326-7-23.
10
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.细胞朊蛋白介导β-淀粉样寡聚体对突触可塑性的损害。
Nature. 2009 Feb 26;457(7233):1128-32. doi: 10.1038/nature07761.

本文引用的文献

1
Tau Oligomer-Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer Disease.阿尔茨海默病中小胶质细胞和星形胶质细胞清除含有 Tau 寡聚物的突触。
JAMA Neurol. 2023 Nov 1;80(11):1209-1221. doi: 10.1001/jamaneurol.2023.3530.
2
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.多奈哌齐治疗早期症状性阿尔茨海默病的随机临床试验。
JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239.
3
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
4
The role of wild-type tau in Alzheimer's disease and related tauopathies.野生型tau蛋白在阿尔茨海默病及相关tau蛋白病中的作用。
J Life Sci (Westlake Village). 2020 Dec;2(4):1-17. doi: 10.36069/jols/20201201.
5
Molecular characterization of selectively vulnerable neurons in Alzheimer's disease.阿尔茨海默病中选择性易损神经元的分子特征。
Nat Neurosci. 2021 Feb;24(2):276-287. doi: 10.1038/s41593-020-00764-7. Epub 2021 Jan 11.
6
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?阿尔茨海默病中的神经炎症和小胶质细胞激活：我们的路在何方？
Nat Rev Neurol. 2021 Mar;17(3):157-172. doi: 10.1038/s41582-020-00435-y. Epub 2020 Dec 14.
7
Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer's disease, progressive supranuclear palsy and dementia with Lewy bodies.阿尔茨海默病、进行性核上性麻痹和路易体痴呆患者脑源性 tau 寡聚物的内化机制。
Cell Death Dis. 2020 May 4;11(5):314. doi: 10.1038/s41419-020-2503-3.
8
The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer's Disease (AD).蛋白质错误折叠和 tau 寡聚物（tauOs）在阿尔茨海默病（AD）中的作用。
Int J Mol Sci. 2019 Sep 20;20(19):4661. doi: 10.3390/ijms20194661.
9
The neuropathological diagnosis of Alzheimer's disease.阿尔茨海默病的神经病理学诊断。
Mol Neurodegener. 2019 Aug 2;14(1):32. doi: 10.1186/s13024-019-0333-5.
10
Expansion microscopy: principles and uses in biological research.扩展显微镜：在生物研究中的原理和应用。
Nat Methods. 2019 Jan;16(1):33-41. doi: 10.1038/s41592-018-0219-4. Epub 2018 Dec 20.